Michael Anthony Serna, MD
Psychiatry · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 3 carriers
- Offices
- 3
Offices
3 locations · Psychplus Associates of California PC · Precision Psychiatric Services Inc · Psychiatry of Texas PLLC
Looking this up.
Plans that list them
20 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Serna’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A144859 · Current
Licensed to practise in California · since 2016 · expires 2028-03-31 · Autonomous University of Guadalajara Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$174,880
Medicare paid this office $174,880 for 185 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $132,924 | $106 |
| Psychiatric diagnostic evaluation with medical services | 104 | $15,480 | $149 |
| Hospital discharge day management, more than 30 minutes | 98 | $10,752 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $7,532 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $4,031 | $106 |
Who their Medicare patients are
185 Original Medicare patients in 2024. Average age 46 · Under 65 89% · Women 49% · Also on Medicaid 88% · Health risk score 1.14. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 55% · High blood pressure 45% · Diabetes 24% · COPD 11% · Chronic kidney disease 9% · Coronary heart disease 6%.
The office billed $477,112, Medicare allowed $219,939 and paid $174,880; for 1,659 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 185 | 1,659 | 46 | 1.14 | $477,112 | $174,880 |
| 2023 | 123 | 768 | 42 | 1.01 | $221,960 | $82,915 |
| 2022 | 167 | 1,173 | 46 | 0.97 | $353,702 | $115,790 |
| 2021 | 107 | 593 | 54 | 1.69 | $183,462 | $60,076 |
| 2020 | 77 | 181 | 70 | 2.06 | $56,140 | $8,519 |
| 2019 | 92 | 531 | 73 | 1.99 | $148,599 | $23,473 |
| 2018 | 96 | 548 | 70 | 2.30 | $164,756 | $34,717 |
| 2017 | 32 | 42 | 71 | 2.16 | $13,968 | $3,368 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 115 | $68,746 | $107 |
| Psychiatric diagnostic evaluation with medical services | 53 | $7,985 | $151 |
| Hospital discharge day management, more than 30 minutes | 29 | $3,244 | $105 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $86,579 | $93 |
| Psychiatric diagnostic evaluation with medical services | 105 | $17,156 | $153 |
| Hospital discharge day management, more than 30 minutes | 85 | $8,948 | $97 |
2021: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $42,062 | $93 |
| Psychiatric diagnostic evaluation with medical services | 74 | $11,491 | $151 |
| Hospital discharge day management, more than 30 minutes | 37 | $3,960 | $99 |
2020: 4 services
| Psychiatric diagnostic evaluation with medical services | 22 | $2,795 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,727 | $86 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 41 | $1,463 | $16 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 16 | $1,170 | $38 |
2019: 4 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 64 | $11,446 | $33 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 50 | $5,923 | $49 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 15 | $1,995 | $133 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 19 | $1,710 | $71 |
2018: 5 services
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 42 | $9,975 | $102 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 58 | $8,180 | $35 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 42 | $5,746 | $131 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 58 | $5,670 | $54 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 31 | $2,411 | $67 |
2017: 1 service
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 11 | $1,383 | $106 |
Medicaid work
$9,121 in 2024
Medicaid paid $9,121 for 182 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 182 | $9,121 |
| 2024 | 182 | 1 | 16 | $9,121 |
| 2023 | 58 | 1 | 12 | $1,094 |
| 2022 | 27 | 1 | 15 | $0 |
| 2021 | 12 | 1 | 12 | $316 |
| 2020 | 152 | 4 | 21 | $17,562 |
| 2019 | 257 | 3 | 29 | $24,930 |
| 2018 | 74 | 2 | 21 | $11,117 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 58 | $1,094 |
2022
| Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 27 | $0 |
2021
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $316 |
2020
| Clinic visit/encounter, all-inclusive | 68 | $17,550 |
| SBSQ NURSING FACILITY CARE SF MDM 10 MINUTES | 45 | $12 |
| Short return visit (20+ min) | 27 | $0 |
| Return visit (30+ min) | 12 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 128 | $24,930 |
| Short return visit (20+ min) | 109 | $0 |
| SBSQ NURSING FACILITY CARE SF MDM 10 MINUTES | 20 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 61 | $11,117 |
| Short return visit (20+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$5,315
Pharmacies billed $5,315 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 244) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
238 generic and fewer than 11 brand-name prescriptions · $5,315 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Divalproex | 15 | $200 | $13 |
| Risperidone | 15 | $90 | $6 |
| Olanzapine | 11 | $88 | $8 |
| Gabapentin | 13 | $75 | $6 |
| Hydroxyzine Pamoate | 12 | $68 | $6 |
See all 7 drugs
| Divalproex | 15 | $200 | $13 |
| Risperidone | 15 | $90 | $6 |
| Olanzapine | 11 | $88 | $8 |
| Gabapentin | 13 | $75 | $6 |
| Hydroxyzine Pamoate | 12 | $68 | $6 |
| Quetiapine | 11 | $62 | $6 |
| Trazodone | 14 | $58 | $4 |
Year by year
| 2024 | 244 | 66 | 0% (0) | None | $5,315 |
| 2023 | 150 | 48 | 0% (0) | None | $6,457 |
| 2022 | 225 | 68 | 0% (0) | 7% | $34,323 |
| 2021 | 154 | 42 | 0% (0) | 17% | $53,529 |
| 2020 | 471 | 56 | 0% (0) | 24% | $143,881 |
| 2019 | 1,480 | 103 | None | None | $179,754 |
| 2018 | 849 | 96 | 0% (0) | 6% | $44,783 |
| 2017 | 327 | 48 | 0% (0) | 6% | $20,231 |
| 2016 | 45 | 12 | 0% (0) | 0% | $1,024 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Risperidone | 11 | $129 | $12 |
2022: 6 drugs
| Olanzapine | 21 | $892 | $42 |
| Quetiapine | 16 | $553 | $35 |
| Divalproex | 18 | $337 | $19 |
| Gabapentin | 21 | $241 | $11 |
| Propranolol | 11 | $193 | $18 |
| Risperidone | 12 | $162 | $14 |
2021: 2 drugs
| Ingrezza | 12 | $38,214 | $3,185 |
| Sertraline | 12 | $65 | $5 |
2020: 18 drugs
| Ingrezza | 30 | $87,691 | $2,923 |
| Vraylar | 28 | $17,013 | $608 |
| Latuda | 24 | $14,563 | $607 |
| Olanzapine | 42 | $3,674 | $87 |
| Quetiapine Fumarate Er | 27 | $3,383 | $125 |
| Buprenorphine-Naloxone | 11 | $2,406 | $219 |
| Divalproex Sodium Er | 22 | $2,117 | $96 |
| Aripiprazole | 14 | $1,371 | $98 |
| Valproic Acid | 15 | $946 | $63 |
| Clonazepam | 14 | $528 | $38 |
| Sertraline | 39 | $289 | $7 |
| Trazodone | 25 | $219 | $9 |
| Mirtazapine | 11 | $213 | $19 |
| Benztropine Mesylate | 13 | $175 | $13 |
| Citalopram Hbr | 16 | $137 | $9 |
| Fluoxetine | 19 | $125 | $7 |
| Metformin | 11 | $28 | $3 |
| Alprazolam | 13 | $25 | $2 |
2019: 30 drugs
| Ingrezza | 22 | $77,472 | $3,521 |
| Latuda | 29 | $18,698 | $645 |
| Vraylar | 28 | $16,343 | $584 |
| Risperdal Consta | 27 | $11,430 | $423 |
| Quetiapine Fumarate Er | 55 | $6,564 | $119 |
| Aripiprazole | 42 | $5,719 | $136 |
| Olanzapine | 149 | $3,712 | $25 |
| Divalproex Sodium Er | 43 | $3,462 | $81 |
| Venlafaxine Hcl Er | 42 | $2,512 | $60 |
| Clozapine | 72 | $1,762 | $24 |
| Risperidone | 86 | $1,310 | $15 |
| Quetiapine | 108 | $1,148 | $11 |
| Memantine | 69 | $1,139 | $17 |
| Donepezil | 64 | $1,078 | $17 |
| Sertraline | 134 | $864 | $6 |
| Desvenlafaxine Succinate Er | 13 | $816 | $63 |
| Rivastigmine | 35 | $716 | $20 |
| Divalproex | 39 | $645 | $17 |
| Trazodone | 52 | $612 | $12 |
| Fluoxetine | 66 | $607 | $9 |
| Duloxetine | 12 | $331 | $28 |
| Valproic Acid | 15 | $294 | $20 |
| Clonazepam | 28 | $287 | $10 |
| Mirtazapine | 18 | $265 | $15 |
| Benztropine Mesylate | 16 | $202 | $13 |
| Gabapentin | 14 | $186 | $13 |
| Escitalopram | 30 | $159 | $5 |
| Citalopram Hbr | 15 | $109 | $7 |
| Lorazepam | 11 | $91 | $8 |
| Alprazolam | 11 | $52 | $5 |
2018: 17 drugs
| Aripiprazole | 27 | $3,389 | $126 |
| Donepezil | 132 | $2,608 | $20 |
| Divalproex | 35 | $2,536 | $72 |
| Venlafaxine Hcl Er | 26 | $2,128 | $82 |
| Divalproex Sodium Er | 16 | $1,153 | $72 |
| Trazodone | 58 | $900 | $16 |
| Olanzapine | 66 | $896 | $14 |
| Bupropion Xl | 29 | $874 | $30 |
| Duloxetine | 15 | $854 | $57 |
| Risperidone | 48 | $704 | $15 |
| Clozapine | 54 | $689 | $13 |
| Fluoxetine | 54 | $650 | $12 |
| Memantine | 15 | $434 | $29 |
| Sertraline | 60 | $422 | $7 |
| Quetiapine | 32 | $303 | $9 |
| Escitalopram | 29 | $237 | $8 |
| Gabapentin | 13 | $234 | $18 |
2017: 12 drugs
| Quetiapine Fumarate Er | 16 | $6,945 | $434 |
| Fluoxetine | 23 | $1,416 | $62 |
| Aripiprazole | 17 | $1,181 | $69 |
| Amitriptyline | 19 | $858 | $45 |
| Mirtazapine | 15 | $688 | $46 |
| Duloxetine | 21 | $557 | $27 |
| Bupropion Xl | 16 | $443 | $28 |
| Quetiapine | 21 | $366 | $17 |
| Trazodone | 27 | $327 | $12 |
| Gabapentin | 14 | $278 | $20 |
| Sertraline | 35 | $171 | $5 |
| Olanzapine | 12 | $152 | $13 |
2016: 1 drug
| Fluoxetine | 11 | $75 | $7 |
Money from drug and device companies
$242 in 2025
| 2025 | 6 | 10 | None | $242 |
| 2024 | 4 | 5 | None | $116 |
| 2023 | 7 | 12 | None | $299 |
| 2022 | 5 | 5 | None | $123 |
| 2021 | 2 | 2 | None | $36 |
| 2019 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vanda Pharmaceuticals | Fanapt | $65 | 2 payments
|
| Neurocrine BioSciences | Ingrezza | $63 | 3 payments
|
| Abbvie | Vraylar | $39 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $28 | 1 payment
|
| BioXcel Therapeutics | Igalmi | $25 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $21 | 1 payment
|
See all 10 published payments
| Vanda Pharmaceuticals | Meals · 2025-12-03 | Fanapt | $31 |
| Neurocrine BioSciences | Meals · 2025-10-15 | Ingrezza | $24 |
| Neurocrine BioSciences | Meals · 2025-09-22 | Ingrezza | $19 |
| BioXcel Therapeutics | Meals · 2025-09-18 | Igalmi | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-05 | Cobenfy | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-06-19 | Abilify Maintena | $21 |
| Abbvie | Meals · 2025-05-21 | Vraylar | $17 |
| Vanda Pharmaceuticals | Meals · 2025-05-09 | Fanapt | $35 |
| Abbvie | Meals · 2025-04-10 | Vraylar | $22 |
| Neurocrine BioSciences | Meals · 2025-02-03 | Ingrezza | $20 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $116
| Abbvie | Vraylar | $47 | 2 payments
|
| Indivior | Perseris | $25 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $24 | 1 payment
|
| Alkermes | Lybalvi | $20 | 1 payment
|
2023: $299
| Janssen Pharmaceuticals | Spravato | $78 | 3 payments
|
| Alkermes | Aristada | $66 | 3 payments
|
| BioXcel Therapeutics | Igalmi | $53 | 2 payments
|
| AbbVie | Vraylar | $33 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $24 | 1 payment
|
| Iti | Caplyta | $24 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $20 | 1 payment
|
2022: $123
| Neurocrine Biosciences | Ingrezza | $33 | 1 payment
|
| Indivior | Perseris | $27 | 1 payment
|
| Alkermes | Aristada | $25 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $24 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $15 | 1 payment
|
2021: $36
| Alkermes | Aristada | $20 | 1 payment
|
| Indivior | Perseris | $17 | 1 payment
|
2019: $22
| Sunovion Pharmaceuticals | Latuda | $22 | 1 payment
|
Professional record
- NPI
- 1548675135
- Licence
- CA A144859California A144859: Current · expires 2028-03-31
- Group
- Psychplus Associates of California PC · Precision Psychiatric Services Inc · Psychiatry of Texas PLLC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 4730 W Caldwell Ave Apt F, Visalia, CA, 93277
- NPI first listed
- 2014-06-23
- NPI last updated
- 2020-06-09
- NPI record certified
- 2020-06-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 496 S Barton Street, Fresno, CA, 93750 · 400 W Mineral King Ave, Visalia, CA, 93291